Biblio

Author Title Type [ Year

]

Filters: Author is Zhang, Xiao-Hui [Clear All Filters]

2024

Liang M, Lyu Z-S, Zhang Y-Y, Tang S-Q, Xing T, Chen Y-H, Wang Y, Jiang Q, Xu L-P, Zhang X-H, et al. Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury. Cancer Lett. 2024:216937.

Wang L-Y, Li Y, Jiang Q, Jiang H, Wang Y, Xu L-P, Zhang X-H, Liu K-Y, Tang F-F. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis. Hematol Oncol. 2024;42(2):e3256.

Cai X, Gui R-Y, Wu J, Wang C-C, Zhu X-L, Fu H-X, Zhang X-H. Decreased Expression of IL-35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia. Adv Sci (Weinh). 2024:e2305798.

Cheng C, Deng D-X, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, et al. Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment. Front Oncol. 2024;14:1390438.

Wu L-X, Zhao M-Y, Yan N, Zhou Y-L, Cao L-M, Qin Y-Z, Jiang Q, Xu L-P, Zhang X-H, Huang X-J, et al. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia. Clin Exp Med. 2024;24(1):56.

Chen Y, Xu L-P, Zhang X-H, Chen H, Liu K-Y, Qing J, Yang Y-L, Huang X-J. Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X-linked adrenal cerebral leukodystrophy. Pediatr Transplant. 2024;28(3):e14735.

Liu F-Q, Qu Q-Y, Lei Y, Chen Q, Chen Y-X, Li M-L, Sun X-Y, Wu Y-J, Huang Q-S, Fu H-X, et al. High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia. Sci China Life Sci. 2024.

Wang Y, Liu Q-F, Wu D-P, Xu Z-L, Han T-T, Sun Y-Q, Huang F, Fan Z-P, Xu N, Chen F, et al. Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC Med. 2024;22(1):176.

Hu G-H, Zhang X-H, Liu K-Y, Xu L-P, Wang Y, Cheng Y-F, Huang X-J. Outcome and prognostic factors of haploidentical allogeneic hematopoietic stem cell transplantation in pediatric relapsed or refractory ETV6/RUNX1-positive acute lymphoblastic leukemia. Acta Haematol. 2024.

Cao X-H, Fan Z-Y, Chang Y-J, Xu L-P, Zhang X-H, Huang X-J, Zhao X-Y. Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation. J Transl Med. 2024;22(1):244.

Hu G-H, Zhang X-H, Wang Y, Xu L-P, Hou X-L, Cheng Y-F, Huang X-J. The prognosis of haploidentical hematopoietic stem cell transplantation in infants and patients under 3 years old with acute leukemia. Clin Transplant. 2024;38(2):e15247.

Ma R, Zhu D-P, Zhang X-H, Xu L-P, Wang Y, Mo X-D, Lv M, Zhang Y-Y, Cheng Y-F, Yan C-H, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transplant. 2024.

2023

Kong J, Zheng F-M, Wang Z-D, Zhang Y-Y, Cheng Y-F, Fu H-X, Lv M, Chen H, Xu L-P, Zhang X-H, et al. Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.

Huang Q, Zhang X-H, Liu D. CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting. J Hematol Oncol. 2023;16(1):18.

Huang Q-S, Han T-X, Chen Q, Wu J, Zhao P, Wu Y-J, He Y, Zhu X-L, Fu H-X, Wang F-R, et al. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.

Sun Y-Q, Zhang X-H, Jiang Q, Jiang H, Chang Y-J, Wang Y, Xu L-P, Liu K-Y, Huang X-J. Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia. Bone Marrow Transplant. 2023.

Yu W-J, Sun Y-Q, Xu L-P, Zhang X-H, Liu K-Y, Huang X-J, Wang Y. Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission. Ann Hematol. 2023.

Cao L-M, Zhou Y-L, Gale RPeter, Qin Y-Z, Wu L-X, Zhao M-Y, Zhao X-S, Chen Y-H, Wang Y, Jiang H, et al. CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia. Biomol Biomed. 2023.

Ma L, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia. Front Oncol. 2023;13:1166990.

Shang Q-N, Yu X-X, Xu Z-L, Chen Y-H, Han T-T, Zhang Y-Y, Lv M, Sun Y-Q, Wang Y, Xu L-P, et al. Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection. Cell Mol Immunol. 2023.

Yue K, Gao H, Liang S, Wu N, Cheng C, Xu L-P, Zhang X-H, Wang Y, Cheng Y, Huang X-J, et al. Improved Vδ2 T cells recovery correlates to reduced incidences of mortality and relapse in acute myeloid leukemia after hematopoietic transplantation. Ann Hematol. 2023.

An Z-Y, Wu Y-J, Hou Y, Mei H, Nong W-X, Li W-Q, Zhou H, Feng R, Shen J-P, Peng J, et al. A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull (Beijing). 2023.

Xu Z-L, Xu L-P, Zhang Y-Y, Cheng Y-F, Mo X-D, Han T-T, Wang F-R, Yan C-H, Sun Y-Q, Chen Y-H, et al. Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation. Bone Marrow Transplant. 2023.

Zhou Y-L, Zhao M-Y, Gale RPeter, Jiang H, Jiang Q, Liu L-X, Qin J-Y, Cao S-B, Lou F, Xu L-P, et al. Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia. 2023.

Zhang F, Hu G-H, Zhang L-P, Xu L-P, Suo P, Wang Y, Bai L, Liu K-Y, Zhang X-H, Huang X-J, et al. Outcomes of haploidentical hematopoietic stem cell transplantation with 'Beijing protocol' in pediatric myeloid neoplasms post cytotoxic therapy: a case series study. Leuk Lymphoma. 2023:1-6.

Pages